Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260409004) titled 'The outcome of self-sampling HPV test for primary cervical cancer screening program in Phitsanulok' on April 9.

Study Type: Observational

Primary Sponsor: Ruangsak Ruansukon

Condition: High-risk human papillomavirus (HR-HPV) infection among women undergoing primary cervical cancer screening using self-sampling in Phitsanulok province. High-risk HPV, Self-sampling HPV test, Cervical cancer screening, Cervical histopathology High-risk HPV, Self-sampling HPV test, Cervical cancer screening, Cervical histopathology

Intervention: Women aged 30 to 60 years who voluntarily participated in this study.,w...